UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice

Blood, 2012-03, Vol.119 (13), p.3164-3175

2012

Volltextzugriff (PDF)

CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study

Arthritis research & therapy, 2015-09, Vol.17 (1), p.234, Article 234

2015

Volltextzugriff (PDF)

Anti-CD40L immune complexes potently activate platelets in vitro and cause thrombosis in FCGR2A transgenic mice

The Journal of immunology (1950), 2010-08, Vol.185 (3), p.1577-1583

2010

Volltextzugriff (PDF)

Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer

Thrombosis research, 2016-05, Vol.141, p.39-48

2016

Volltextzugriff (PDF)

Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin

Thrombosis and haemostasis, 2006-12, Vol.96 (6), p.816-821

2006

Volltextzugriff (PDF)

Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer

Thrombosis and haemostasis, 2009-06, Vol.101 (6), p.1147-1155

2009

Volltextzugriff (PDF)

Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454

Thrombosis and haemostasis, 2003-09, Vol.90 (3), p.549-554

2003

Volltextzugriff (PDF)

Tissue factor-dependent and -independent pathways of systemic coagulation activation in acute myeloid leukemia: a single-center cohort study

Experimental hematology & oncology, 2015-08, Vol.4 (1), p.22-22, Article 22

2015

Volltextzugriff (PDF)

The role of CD40 in CD40L- and antibody-mediated platelet activation

Thrombosis and haemostasis, 2005-06, Vol.93 (6), p.1137-1146

2005

Volltextzugriff (PDF)

Tissue factor pathway inhibitor reduces experimental lung metastasis of B16 melanoma

Thrombosis and haemostasis, 2002, Vol.87 (6), p.930-936

2002

Volltextzugriff (PDF)

Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers

Thrombosis and haemostasis, 2007-03, Vol.97 (3), p.464-470

2007

Volltextzugriff (PDF)

The presence and release of tissue factor from human platelets

Platelets (Edinburgh), 2002, Vol.13 (4), p.247-253

2002

Volltextzugriff (PDF)

The Role of Human Fc Gamma Receptors in the Pathophysiology of Lupus Syndrome

The FASEB journal, 2019-04, Vol.33 (S1), p.802.8-802.8

2019

Volltextzugriff (PDF)

An Antibody-Drug Conjugate That Targets Tissue Factor Exhibits Potent Therapeutic Activity against a Broad Range of Solid Tumors

Cancer research (Chicago, Ill.), 2014-02, Vol.74 (4), p.1214-1226

2014

Volltextzugriff (PDF)

In Vitro and In Vivo Characterization of a Novel Antibody-Like Single-Chain TCR Human IgG1 Fusion Protein

The Journal of immunology (1950), 2005-04, Vol.174 (7), p.4381-4388

2005

Volltextzugriff (PDF)

An in vitro study on the mechanisms of coagulation activation in acute myelogenous leukemia (AML): role of tissue factor regulation by cytotoxic drugs and GM-CSF

Thrombosis and haemostasis, 2004-11, Vol.92 (5), p.1136-1146

2004

Volltextzugriff (PDF)

Effective inhibition of experimental metastasis and prolongation of survival in mice by a potent factor Xa-specific synthetic serine protease inhibitor with weak anticoagulant activity

Thrombosis and haemostasis, 2005-11, Vol.94 (5), p.1084-1093

2005

Volltextzugriff (PDF)

CalDAG‐GEFI deficiency protects mice from FcγRIIa‐mediated thrombotic thrombocytopenia induced by CD40L and β2GPI immune complexes

Journal of thrombosis and haemostasis, 2014-12, Vol.12 (12), p.2113-2119

2014

Volltextzugriff (PDF)

Blockade of the Neonatal Fc Receptor (FcRn) Represents an Effective Mechanism for the Removal of Pathogenic Autoantibodies in Primary Immune Thrombocytopenia

Blood, 2017-12, Vol.130, p.230-230

2017

Volltextzugriff (PDF)

CD32a antibodies induce thrombocytopenia and type II hypersensitivity reactions in FCGR2A mice

Blood, 2015-11, Vol.126 (19), p.2230-2238

2015

Volltextzugriff (PDF)

Functional characterization of a VEGF-A-targeting Anticalin, prototype of a novel therapeutic human protein class

Angiogenesis (London), 2016-01, Vol.19 (1), p.79-94

2016

Volltextzugriff (PDF)

Aflibercept exhibits VEGF binding stoichiometry distinct from bevacizumab and does not support formation of immune-like complexes

Angiogenesis (London), 2016-07, Vol.19 (3), p.389-406

2016

Volltextzugriff (PDF)

Pentoxifylline inhibits hypoxia-induced upregulation of tumor cell tissue factor and vascular endothelial growth factor

Thrombosis and haemostasis, 1998-10, Vol.80 (4), p.598

1998

Volltextzugriff (PDF)

The Role of Tissue Factor Pathway Inhibitor in Tumor Growth and Metastasis

Seminars in thrombosis and hemostasis, 2007-10, Vol.33 (7), p.643-652

2007

Volltextzugriff (PDF)

Differential Effects of Protein Disulfide Isomerase (PDI) Inhibitors On the Expression of Tissue Factor Procoagulant Activity (TF PCA) by AML Blasts

Blood, 2012-11, Vol.120 (21), p.1112-1112

2012

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(75)
Buchkapitel
(1)

Sprache

Englisch
(76)

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(42)
Humans
(33)
Hematology
(28)
Animals
(23)
Cardiovascular System & Cardiology
(20)
Peripheral Vascular Disease
(19)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Mice
(15)
Female
(11)
Tissue Factor
(10)
Cancer
(9)
Metastasis
(9)
Fundamental And Applied Biological Sciences. Psychology
(8)
Hematologic And Hematopoietic Diseases
(8)
Blood Coagulation. Blood Cells
(7)
Lung Neoplasms - Secondary
(7)
Molecular And Cellular Biology
(7)
Oncology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice

CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study

Anti-CD40L immune complexes potently activate platelets in vitro and cause thrombosis in FCGR2A transgenic mice

Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer

Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin

Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer

Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454

Tissue factor-dependent and -independent pathways of systemic coagulation activation in acute myeloid leukemia: a single-center cohort study

The role of CD40 in CD40L- and antibody-mediated platelet activation

Tissue factor pathway inhibitor reduces experimental lung metastasis of B16 melanoma

Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers

The presence and release of tissue factor from human platelets

The Role of Human Fc Gamma Receptors in the Pathophysiology of Lupus Syndrome

An Antibody-Drug Conjugate That Targets Tissue Factor Exhibits Potent Therapeutic Activity against a Broad Range of Solid Tumors

In Vitro and In Vivo Characterization of a Novel Antibody-Like Single-Chain TCR Human IgG1 Fusion Protein

An in vitro study on the mechanisms of coagulation activation in acute myelogenous leukemia (AML): role of tissue factor regulation by cytotoxic drugs and GM-CSF

Effective inhibition of experimental metastasis and prolongation of survival in mice by a potent factor Xa-specific synthetic serine protease inhibitor with weak anticoagulant activity

CalDAG‐GEFI deficiency protects mice from FcγRIIa‐mediated thrombotic thrombocytopenia induced by CD40L and β2GPI immune complexes

Blockade of the Neonatal Fc Receptor (FcRn) Represents an Effective Mechanism for the Removal of Pathogenic Autoantibodies in Primary Immune Thrombocytopenia

CD32a antibodies induce thrombocytopenia and type II hypersensitivity reactions in FCGR2A mice

Functional characterization of a VEGF-A-targeting Anticalin, prototype of a novel therapeutic human protein class

Aflibercept exhibits VEGF binding stoichiometry distinct from bevacizumab and does not support formation of immune-like complexes

Pentoxifylline inhibits hypoxia-induced upregulation of tumor cell tissue factor and vascular endothelial growth factor

The Role of Tissue Factor Pathway Inhibitor in Tumor Growth and Metastasis

Differential Effects of Protein Disulfide Isomerase (PDI) Inhibitors On the Expression of Tissue Factor Procoagulant Activity (TF PCA) by AML Blasts

Suchergebnisse filtern